It is indicated that chronic stress alters Pnoc and mRNA levels of Pnoc-expressing cells in a sex-selective and region-specific manner impacting reward structures, and that NOPR antagonism shows promising efficacy in increasing reward-related behaviors in rodents and humans.
Abstract
Nociceptin orphanin F/Q has been implicated in stress-related depressive phenotypes. Specifically, exposure to chronic stressors upregulates nociceptin receptors (NOPR), whereas NOPR antagonism has antidepressant/anti-anhedonic effects. However, the mechanisms underlying reward-related effects remain unclear. Here, we investigated the role of NOPR in a broad spectrum of reward-related phenotypes (reward consumption, reward learning, motivated behavior) alongside potentially prohedonic effects of NOPR antagonism across species. Study 1 evaluated whether exposure to early-life adversity upregulated ventral tegmental area (VTA) and striatal prepronociceptin (Pnoc) gene expression in adult mice. Study 2 assessed whether NOPR antagonism boosted reward learning in rats using the touchscreen-based Probabilistic Reward Task. Finally, Study 3 tested whether NOPR antagonism modulated decision about motivated behavior using the Effort Expenditure for Reward Task among depressed humans. In Study 1, early-life adversity induced reduced sucrose preference and produced enduring and sex-dependent alterations in effort-related reward behavior, and increased Pnoc expression in the VTA; in females (but not males), early-life adversity increased Pnoc expression in the dorsal striatum. In Study 2, acute administration of 30 mg/kg (but not lower doses) of a NOPR antagonist (BTRX-246040) enhanced reward learning in rats. Finally, in Study 3, relative to placebo, 8-week treatment with BTRX-246040 modulated choice consistency during a motivated task in depressed humans. Collectively, our findings indicate that chronic stress alters Pnoc and mRNA levels of Pnoc-expressing cells in a sex-selective and region-specific manner impacting reward structures, and that NOPR antagonism shows promising efficacy in increasing reward-related behaviors in rodents and humans. Future studies using similar manipulations and outcome measures across species are warranted.
It is found CRH signaling via CRHR1 indeed disrupts reward behaviors in naïve mice, but is dysregulated in ‘anhedonic’ mice with a history of ELA, and activation of CRH receptor 2 (CRHR2) reverses anhedonia-like behaviors in adult ELA mice.
Matthew T. Birnie, Lara Taniguchi, Lia M. Harvey et al.· bioRxiv· 0 citations
Abstract Background Psilocybin has shown therapeutic potential for several neuropsychiatric disorders; however, concerns remain regarding its abuse liability and long-term neurobiological effects following repeated use. While acute psychedelic administration is generally considered to have low addictive potential, the...
V. Bruno, M. López-Canúl, B. Richardson et al.· International Journal of Neu...· 0 citations
It is indicated that prior exposure to N-ADA can influence reward- and anxiety-related behaviors specifically under conditions of CB1 blockade/GPR55 modulation and an interaction with endocannabinoid signaling (or other rimonabant-sensitive mechanisms) is indicated.
Oliver A. Colis-Arenas, Katya Ch Navarro-Montellano, Carlos H. López-Lariz et al.· Physiology and Behavior· 0 citations
ABSTRACT Morphine‐associated contextual reward learning promotes maladaptive drug–context associations during opioid exposure. Hederagenin (HE), a bioactive compound from traditional Chinese medicine, has neuroprotective potential, but its role in contextual reward learning remains unclear. Here, we investigated the ef...
Hong-Yan Jiang, Zi-Ting Zhou, Nan-Nan Xue et al.· Advancement of science· 0 citations
The comparable efficacy of ESC and BChEI in reversing CPP deficits highlights the therapeutic responsiveness of consummatory anhedonia, strengthening the translational validity of the FSL model and position the BChE-ghrelin-dopamine pathway as a promising avenue for further mechanistic exploration in MDD research.
N. Olivier, C. Brink, A. Haasbroek-Pheiffer et al.· International Journal of Neu...· 0 citations
A mechanistic framework in which CRF-mediated recruitment of hypothalamic OX neurons contributes to neuroplasticity deficits in the mPFC, HIPP, and AMY is proposed, which positions OX transmission as a potential link between chronic stress and mood-related psychopathology.
Alexa C. E. Alcala, Sophia C. Bellitire, Katherine Brunson et al.· Frontiers in Psychiatry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.